Speaker illustration

Doctor Anna Lena Hohneck

University Medical Centre of Mannheim, Mannheim (Germany)

Member of:

European Society of Cardiology

Central hemodynamic effects in patients with chronic coronary syndrome after long-term ivabradine therapy

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Chronic Ischaemia

Session: Coronary Artery Disease (Chronic) ePosters


Risk stratification of patients with Brugada syndrome (BrS): The impact of myocardial strain analysis using cardiac magnetic resonance myocardial feature tracking (CMR-FT)

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Deformation Imaging

Session: Cardiac Magnetic Resonance ePosters


Heart rate reduction with ivabradine restores endothelial function and reduces vascular stiffness in patients with chronic stable coronary artery disease

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation


Presence of late gadolinium enhancement and left atrial ejection fraction as predictors of stroke and thrombembolism in patients with hypertrophic cardiomyopathy - a cardiovascular MRI study -

Event: ESC Congress 2018

Topic: Late Gadolinium Enhancement

Session: Late gadolinium enhancement and viability


ESC 365 is supported by

logo Novo Nordisk